444 related articles for article (PubMed ID: 15527055)
1. An evaluation of clinical and histopathological status in paucibacillary leprosy patients after completion of fixed duration therapy.
Mathew D; Kishore BN; Shwethadri GK; Sukumar ; Shetty NJ
Indian J Lepr; 2004; 76(1):11-8. PubMed ID: 15527055
[TBL] [Abstract][Full Text] [Related]
2. Daily multidrug therapy for leprosy; results of a fourteen-year experience.
de Carsalade GY; Wallach D; Spindler E; Pennec J; Cottenot F; Flageul B
Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752
[TBL] [Abstract][Full Text] [Related]
3. Fixed duration MDT in paucibacillary leprosy.
Mathai R; George S; Jacob M
Int J Lepr Other Mycobact Dis; 1991 Jun; 59(2):237-41. PubMed ID: 2071980
[TBL] [Abstract][Full Text] [Related]
4. Delayed resolution versus treatment failure in paucibacillary leprosy patients under six months fixed duration multidrug therapy.
Job CK; Jayakumar J; Aschhoff M
Indian J Lepr; 1997; 69(2):131-42. PubMed ID: 9290964
[TBL] [Abstract][Full Text] [Related]
5. Relapse as histoid leprosy after receiving multidrug therapy (MDT); a report of three cases.
Shaw IN; Ebenezer G; Rao GS; Natrajan MM; Balasundaram B
Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):272-6. PubMed ID: 11221089
[TBL] [Abstract][Full Text] [Related]
6. Relapses among leprosy patients treated with multidrug therapy: experience in the leprosy control program of the All Africa Leprosy and Rehabilitation Training Center (ALERT) in Ethiopia; practical difficulties with diagnosing relapses; operational procedures and criteria for diagnosing relapses.
Becx-Bleumink M
Int J Lepr Other Mycobact Dis; 1992 Sep; 60(3):421-35. PubMed ID: 1474281
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of single-dose ROM therapy plus low-dose convit vaccine as an adjuvant for treatment of paucibacillary leprosy patients with a single skin lesion.
Majumder V; Saha B; Hajra SK; Biswas SK; Saha K
Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):283-90. PubMed ID: 11221091
[TBL] [Abstract][Full Text] [Related]
8. Silent iritis in treated bacillary negative leprosy.
Thompson K; Job CK
Int J Lepr Other Mycobact Dis; 1996 Sep; 64(3):306-10. PubMed ID: 8862265
[TBL] [Abstract][Full Text] [Related]
9. A clinico-pathological study of multidrug regimen in paucibacillary leprosy.
Kar PK; Jha PK; Panayach JS; Snehi PS
Indian J Lepr; 1988 Apr; 60(2):235-41. PubMed ID: 3192972
[TBL] [Abstract][Full Text] [Related]
10. Four-year follow-up results of a WHO-recommended multiple-drug regimen in paucibacillary leprosy patients in Malawi.
Boerrigter G; Pönnighaus JM; Fine PE; Wilson RJ
Int J Lepr Other Mycobact Dis; 1991 Jun; 59(2):255-61. PubMed ID: 2071983
[TBL] [Abstract][Full Text] [Related]
11. Response of leprosy patients with single lesions to MDT.
Katoch K; Natrajan M; Yadav VS; Bhatia AS
Acta Leprol; 1995; 9(3):133-7. PubMed ID: 7631584
[TBL] [Abstract][Full Text] [Related]
12. Histological changes in tuberculoid leprosy after fixed duration multidrug therapy for six months.
Lavania RK; Girdhar A; Girdhar BK; Desikan KV
Acta Leprol; 1990; 7(2):169-74. PubMed ID: 2220301
[TBL] [Abstract][Full Text] [Related]
13. Duration of multidrug therapy in paucibacillary leprosy patients; experience in the leprosy control program of the All Africa Leprosy and Rehabilitation Training Center (ALERT) in Ethiopia.
Becx-Bleumink M
Int J Lepr Other Mycobact Dis; 1992 Sep; 60(3):436-44. PubMed ID: 1474282
[TBL] [Abstract][Full Text] [Related]
14. Study of multidrug therapy in paucibacillary leprosy.
Kar PK; Sohi AS
J Indian Med Assoc; 1989 Feb; 87(2):34-6. PubMed ID: 2674283
[TBL] [Abstract][Full Text] [Related]
15. Clinical and histopathological activity in paucibacillary leprosy patients after fixed-duration multidrug therapy.
Ebenezer GJ; Suneetha S; Arunthathi S
Lepr Rev; 1997 Sep; 68(3):218-24. PubMed ID: 9364822
[TBL] [Abstract][Full Text] [Related]
16. Relapses in paucibacillary leprosy after MDT--a clinical study.
Grugni A; Nadkarni NJ; Kini MS; Mehta VR
Int J Lepr Other Mycobact Dis; 1990 Mar; 58(1):19-24. PubMed ID: 2319185
[TBL] [Abstract][Full Text] [Related]
17. Occurrence and management of leprosy reaction in China in 2005.
Shen J; Liu M; Zhou M; Wengzhong L
Lepr Rev; 2009 Jun; 80(2):164-9. PubMed ID: 19743620
[TBL] [Abstract][Full Text] [Related]
18. Multidrug therapy for treatment of paucibacillary leprosy in western Kenya--preliminary communications.
Orege PA; Obura M; Okelo C; Okuku P; Makokha S; Nyawalo J
East Afr Med J; 1990 Sep; 67(9):632-9. PubMed ID: 2253572
[TBL] [Abstract][Full Text] [Related]
19. Fixed duration MDT in paucibacillary leprosy (classical and modified).
Nadkarni NJ; Grugni A; Kini MS
Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):25-8. PubMed ID: 8326177
[TBL] [Abstract][Full Text] [Related]
20. Relapse of paucibacillary leprosy after short course multidrug therapy.
Pavithran K
Indian J Lepr; 1988 Apr; 60(2):225-9. PubMed ID: 3192971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]